Related Experiment Videos
Chondroitin sulfate and joint disease
1Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Great Britain.
Osteoarthritis and Cartilage
|September 23, 1998
Summary
Changes in chondroitin sulfate (CS) structure during early joint disease reflect cellular responses. Monoclonal antibodies detect these CS alterations, indicating tight chondrocyte control over biosynthesis for specific functions.
Area of Science:
- Biochemistry
- Cell Biology
- Rheumatology
Background:
- Chondroitin sulfate (CS) is a major component of articular cartilage aggrecan.
- Early joint disease involves alterations in CS chain length and sulfation patterns.
Purpose of the Study:
- To investigate changes in chondroitin sulfate structure during early joint disease.
- To explore the cellular response of chondrocytes to cartilage matrix damage.
Main Methods:
- Utilized monoclonal antibodies to detect alterations in chondroitin sulfate.
- Analyzed changes in chain length and sulfation patterns of chondroitin sulfate.
Main Results:
- Detected specific changes in chondroitin sulfate chain length and sulfation in early joint disease.
- Monoclonal antibody detection correlated with chondrocyte response to matrix damage.
Conclusions:
- Chondroitin sulfate biosynthesis is tightly controlled by chondrocytes.
- Specific sulfation patterns in chondroitin sulfate chains are expressed for distinct biological functions.